| abstract |
The present disclosure relates to novel compounds, pharmaceutical compositions containing the compounds, and methods of using the compounds and pharmaceutical compositions for the treatment of neurodegenerative diseases, including Alzheimer's disease and cognitive decline. Also disclosed are methods for inhibiting the decline in synaptic number or abnormal membrane trafficking associated with exposure of neuronal cells to A[beta] species. |